Clinical Trial

Gram Stain of the First Urine After Puncture in Percutaneous Nephrolithotomy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results. Investigators aimed to test its diagnostic value in predicting and preventing complications.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-26.
Trial Details
NCT Number NCT06393062
Lead Sponsor Adiyaman University
Conditions Percutaneous Nephrolithotomy
Enrollment 245 participants
Start Date 2022-12-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-22